Immuno-Oncotherapeutic Approaches in Advanced Hepatocellular Carcinoma

Advanced hepatocellular carcinoma has limited treatment options, but there has been extensive growth recently with cabozantinib, regorafenib, lenvatinib, nivolumab, atezolizumab, and bevacizumab, which are some of the treatments that have received FDA approval just over the last three years. Because...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Robin Park, Fariha Eshrat, Mohammed Al-Jumayli, Azhar Saeed, Anwaar Saeed
Формат: Artigo
Язык:Inglês
Опубликовано: MDPI AG 2020-08-01
Серии:Vaccines
Предметы:
hepatocellular carcinoma
PD-L1
CTLA-4
oncolytic viruses
antigen peptide vaccines
DC vaccines
Online-ссылка:https://www.mdpi.com/2076-393X/8/3/447
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы